Radiesse
Radiesse® (+) 1.5ml with Lidocaine
- Matched tier
- Calculating...
- Per-unit price
- Calculating...
- Line total
- Calculating...
For licensed and appropriately qualified practitioners, Radiesse® (+) 1.5ml with Lidocaine provides a calcium hydroxylapatite (CaHA) injectable implant suspended in a gel carrier from Merz Aesthetics. Its professional role covers correction of moderate to severe facial wrinkles and folds, including nasolabial folds, and authorised jawline augmentation, making it a CaHA option with integrated local anaesthetic for established facial fold and contour applications.
The (+) 1.5ml presentation contains 0.3% lidocaine and is distinct from the non-lidocaine RADIESSE® syringes. It comes as a sterile 1.5ml pre-filled syringe. The CaHA particles are radiopaque and suspended in a cohesive gel carrier alongside the integrated local anaesthetic. Meds-Go provides licensed-channel sourcing, product-level traceability, and storage under the verified pack conditions.
Key Features
- Synthetic calcium hydroxylapatite particles suspended in a cohesive gel carrier; manufacturer: Merz Aesthetics.
- Variant: lidocaine-containing formulation in 1.5ml.
- Applications: correction of moderate to severe facial wrinkles and folds, including nasolabial folds, and authorised jawline augmentation.
- Range position: lidocaine-containing 1.5ml member of the RADIESSE® implant range.
- Presentation: a sterile 1.5ml pre-filled syringe.
- Supply: account-gated professional ordering through licensed channels.